XLV vs XPH
YTDYear to date
XLV wins+4.9 pts
Past year
XPH wins+4.8 pts
Fee
XLV winslower fee
Yield
XLV wins+1.0 pt
AUM
XLV107.1× more
3–1XLV wins
XLV and XPH · year-to-date · as of Nov 8, 2026 · AUM not scored
XPH vs XLV
YTD$64.75 · +3.4% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareXLV+ S&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return+3.4%+1.8%−7.6%+15.9%+33.8%+86.1%+43.7%+423.4%
Peer average+0.8%+5.8%+2.9%+20.5%+29.5%+75.3%+27.5%—
S&P 500 · VOO+0.3%−5.0%−4.6%+8.7%+9.8%+80.8%+71.8%+793.2%
SPDR XPH and XLV · total return, dividends in · as of Nov 8, 2026
XPH’s Holdings
Today[…] The fund reports no holdings yet.
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.9% | +20.9% | $49.9B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.8% | +19.8% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +25.0% | +25.0% | $10.0B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +20.0% | +20.0% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +17.0% | +17.0% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.5% | −7.0% | −7.0% | $4.0B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +19.9% | +19.9% | $4.0B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +56.9% | +56.9% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.8% | +26.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.4% | +24.4% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +23.1% | +23.1% | $1.3B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +32.4% | +32.4% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +20.6% | +20.6% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.2% | +17.2% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +22.2% | +22.2% | $584M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +33.9% | +33.9% | $524M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 8, 2026
XPH Payouts by Year
13YLatest payout, Sep 2026
$0.04
a share · every quarter
0.4% yield
0.4% yield
13 years added up
$10.92 a share
$10.92 a share
SPDR XPH · per-share distributions by ex-date · 2014–2026
XPH’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −0.1% | +20.9% | +29.0% | $49.9B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | 0.0% | +19.8% | +27.4% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | +2.6% | +25.0% | +40.0% | $10.0B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −0.2% | +20.0% | +27.9% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.3% | +0.1% | +17.0% | +25.1% | $4.6B | |
| 6 | XPH | State Street SPDR S&P Pharmaceuticals ETFThis fund | 0.35% | 0.4% | +3.4% | +15.9% | +33.8% | $466M |
#21 of 33 this year · #11 cheapest of 39 · sorted by assetsOpen the Sectors table →
XPH and its peer group · total return · as of Nov 9, 2026
Cards for This View
XPH’s Top 10 Holdings
TodayXPH reports no holdings we can show: […]
XPH vs Peer Average
YTDXPHAvsBPeer average
1D+3.4%+0.8%
1M+1.8%+5.8%
3M−7.6%+2.9%
YTD+15.9%+20.5%
1Y+33.8%+29.5%
3Y+86.1%+75.3%
5Y+43.7%+27.5%
4–3XPH wins
38 Health care peers · each row scaled to its leader